GeneDx
GeneDx Q2 Revenues Increase 35 Percent, Boosted by Growth in Exome, Genome Tests
The genetic testing firm is using AI to improve genome interpretation and help customers raise low reimbursement rates for whole-exome testing.
Pacific Biosciences, GeneDx, UW Collaborate on Google-Funded Study of WGS in Neonatal Care
Google will contribute expertise on informatics methods and provide an undisclosed amount of funding, including for reagents, to the project.
GeneDx, Prognos Health Partner on Rare Disease Patient Data to Shorten 'Treatment Odyssey'
The companies will integrate GeneDx's whole-genome and whole-exome datasets into the Prognos Marketplace for custom cohorts.
GeneDx Regains Compliance with Nasdaq Minimum Bid Price Requirement
The company executed a reverse stock split this month after its share price had languished below $1.00 since November.
GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate
Molecular diagnostic testing volume grew across all continuing operations in Q1 as GeneDx completed the shutdown of underperforming Sema4 assets.
Apr 28, 2023
GeneDx to Execute 1-for-33 Reverse Stock Split
May 13, 2022
May 12, 2022
Sema4 Q1 Revenues Decline 16 Percent
Apr 21, 2022
Jan 20, 2022
Jan 18, 2022
Sema4 to Acquire GeneDx for $623M
Nov 5, 2019